Clinical trial
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Effectiveness of DDP733 in Female Patients With Irritable Bowel Syndrome With Constipation
NCT00547469 is registered in ClinicalTrials.gov with Dynogen Pharmaceuticals as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Effectiveness of DDP733 in Female Patients With Irritable Bowel Syndrome With Constipation
- Lead sponsor
- Dynogen Pharmaceuticals
- Phase
- Phase 2/3
- Overall status
- Unknown status
- Start date
- October 31, 2007
- Completion date
- Not reported
- Enrollment
- 360 (estimated)
- Sites
- 69
Conditions
As the registry lists them; a condition with its own page is linked.